Thrombosis and Thromboembolism 2018 The State of the Art for Prevention, Evaluation and Treatment
This special course provides a comprehensive review of the most important changes and advances impacting the care of patients who have—or are at risk for—thrombosis and thromboembolism. Updates in diagnosis, treatment and prevention are provided by world-renowned experts and Harvard Medical School’s leading clinical faculty. The curriculum includes:
New options for testing and diagnosis of thrombotic disorders
Important developments in epidemiology and pathophysiology
Best practices for stroke prevention (and prediction) in atrial fibrillation
Guidance to navigate the nuances of prescribing dual antiplatelet therapy
When and how to use new oral anticoagulants and interventional devices
Personalized medicine and lipid biology
Updated lipid guidelines (and controversies surrounding them)
Expert advice to incorporate the latest science into your practice
This program has provided practical and timely education about innovations in this field since 1987. First-time and returning attendees consistently report that the knowledge they acquire from this update changes their practice and drives better outcomes for patients.
Participants will learn state-of-the-art approaches to preventing VTE in medically ill patients; how dual anti-platelet therapy can prevent MI, stroke, and leg amputation; improved stroke prediction and prevention; and a better understanding of the link between inflammation and thrombotic illnesses.
Attendees stay current with the state of the art for:
DVT/PE diagnosis and testing
Parenteral and oral anticoagulants
Atherothrombosis: etiology, pathophysiology, therapy
Anti-inflammatory therapy to reduce risk of cardiovascular events
Hypercoagulability: testing and management
Pharmacomechanical catheter-directed therapy
New approaches to treat high LDL cholesterol and hypertriglyceridemia
Dual antiplatelet therapy: dose, duration, reversibility
Stroke prevention in atrial fibrillation
Special considerations for VTE in cancer and pregnancy
